Compounds > epigallocatechin gallate
Page last updated: 2024-08-24

epigallocatechin gallate and sulindac

epigallocatechin gallate has been researched along with sulindac in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (33.33)18.2507
2000's5 (55.56)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiki, H; Kai, Y; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M1
Fujiki, H; Imai, K; Matsuyama, S; Nakachi, K; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M1
Fujiki, H1
Fujiki, H; Ohkura, Y; Okabe, S; Suganuma, M1
Fujiki, H; Fujimoto, N; Goto, Y; Imai, K; Matsuyama, S; Nakachi, K; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M1
Hara, Y; Hasegawa, J; Isemura, M; Kishimoto, Y; Kohri, T; Miura, N; Ohishi, T; Shiota, G1
Al-Fageeh, M; Blum, CA; Dashwood, RH; Dashwood, WM; Díaz, GD; Ernst, M; Heath, JK; Li, Q; Orner, GA; Tebbutt, N1
Weinstein, B1
Elahl, HMS; Hassan, ESG; Hassanein, NMA; Hegab, AM1

Reviews

2 review(s) available for epigallocatechin gallate and sulindac

ArticleYear
Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1.
    Mutation research, 2001, Sep-01, Volume: 480-481

    Topics: Animals; Anticarcinogenic Agents; Biomarkers, Tumor; Carcinoma, Squamous Cell; Catechin; Chemoprevention; Cohort Studies; Drug Synergism; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Heterogeneous-Nuclear Ribonucleoproteins; Humans; Intestinal Neoplasms; Japan; Lung Neoplasms; Male; Mice; Mice, Mutant Strains; Okadaic Acid; Oligonucleotide Array Sequence Analysis; Prospective Studies; Ribonucleoproteins; Sulindac; Tea; Tumor Cells, Cultured

2001
Relevance of the concept of oncogene addiction to hormonal carcinogenesis and molecular targeting in cancer prevention and therapy.
    Advances in experimental medicine and biology, 2008, Volume: 617

    Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Catechin; Female; Humans; Male; Neoplasms, Hormone-Dependent; Oncogenes; Prostatic Neoplasms; Sulindac

2008

Other Studies

7 other study(ies) available for epigallocatechin gallate and sulindac

ArticleYear
Synergistic effects of (--)-epigallocatechin gallate with (--)-epicatechin, sulindac, or tamoxifen on cancer-preventive activity in the human lung cancer cell line PC-9.
    Cancer research, 1999, Jan-01, Volume: 59, Issue:1

    Topics: 3T3 Cells; Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Division; Dose-Response Relationship, Drug; Drug Synergism; Humans; Lung Neoplasms; Mice; Sulindac; Tamoxifen; Tea; Tumor Cells, Cultured

1999
Green tea and cancer chemoprevention.
    Mutation research, 1999, Jul-16, Volume: 428, Issue:1-2

    Topics: 3T3 Cells; Animals; Apoptosis; Biological Availability; Breast Neoplasms; Case-Control Studies; Catechin; Drug Synergism; Female; Humans; Japan; Male; Mice; Neoplasms; Sulindac; Tea; Tissue Distribution; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha

1999
Two stages of cancer prevention with green tea.
    Journal of cancer research and clinical oncology, 1999, Volume: 125, Issue:11

    Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Division; Cohort Studies; Drug Synergism; Female; Humans; Kava; Male; Neoplasms; Phytotherapy; Plants, Medicinal; Prospective Studies; Sulindac; Tea; Tissue Distribution; Tumor Necrosis Factor-alpha

1999
Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice.
    Journal of cancer research and clinical oncology, 2001, Volume: 127, Issue:1

    Topics: Adenocarcinoma; Animals; Catechin; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Plant Extracts; Sulindac; Tea

2001
Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane.
    Cancer letters, 2002, Mar-08, Volume: 177, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Azoxymethane; Carcinogens; Catechin; Choristoma; Colon; Colonic Neoplasms; Drug Synergism; In Situ Nick-End Labeling; Incidence; Male; Nucleolus Organizer Region; Precancerous Conditions; Rats; Rats, Inbred F344; Sulindac; Tea

2002
Response of Apc(min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
    Mutation research, 2002, Sep-30, Volume: 506-507

    Topics: Adenomatous Polyposis Coli Protein; Animals; Anti-Inflammatory Agents, Non-Steroidal; beta Catenin; Catechin; Cell Line; Cytoskeletal Proteins; Drug Combinations; Imidazoles; Intestinal Mucosa; Intestinal Neoplasms; Luciferases; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Plant Extracts; Polyps; Sulindac; Tea; Trans-Activators

2002
Chemopreventive effect of sulindac in combination with epigallocatechin gallate or kaempferol against 1,2-dimethyl hydrazine-induced preneoplastic lesions in rats: A Comparative Study.
    Journal of biochemical and molecular toxicology, 2018, Volume: 32, Issue:10

    Topics: 1,2-Dimethylhydrazine; Animals; Anticarcinogenic Agents; beta Catenin; Carcinogens; Catechin; Colonic Neoplasms; Cyclooxygenase 2; Down-Regulation; Drug Therapy, Combination; Kaempferols; Male; Nitric Oxide; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Rats, Sprague-Dawley; Sulindac; Thiobarbituric Acid Reactive Substances

2018